Home >
Entresto Facing Pressure From Diabetes Drugs
News
<>
May 15, 2017
Scrip
Entresto Facing Pressure From Diabetes Drugs
By
Lucie Ellis
With diabetes therapeutics adding cardiovascular risk reduction claims, Novartis’s heart failure drug Entresto could face pressure from new fronts – just as sales start to take off.